|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.50 HKD | -0.97% |
|
+3.39% | +20.00% |
| Capitalization | 14TCr 16TCr 2.03TCr 1.72TCr 1.58TCr 1.5TCr 2.77TCr 1,87600Cr 2.82TCr 19TCr 7.26TCr 91TCr 7.61TCr 7.45TCr 3,20600Cr | P/E ratio 2025 |
146x | P/E ratio 2026 * | 54.1x |
|---|---|---|---|---|---|
| Enterprise value | 13TCr 15TCr 1.87TCr 1.59TCr 1.46TCr 1.38TCr 2.56TCr 1,73100Cr 2.6TCr 17TCr 6.7TCr 84TCr 7.02TCr 6.87TCr 2,95800Cr | EV / Sales 2025 |
8x | EV / Sales 2026 * | 6.81x |
| Free-Float |
93.21% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Innovent Biologics, Inc.
| 1 day | -0.97% | ||
| 1 week | +3.39% | ||
| Current month | +7.77% | ||
| 1 month | +7.84% | ||
| 3 months | +2.23% | ||
| 6 months | +5.35% | ||
| Current year | +20.00% |
| 1 week | 84.85 |  | 93.15 |
| 1 month | 75.9 | | 93.15 |
| Current year | 75.9 | | 93.8 |
| 1 year | 48.05 | | 109.1 |
| 3 years | 27.3 | | 109.1 |
| 5 years | 18.06 | | 109.1 |
| 10 years | 14 | | 109.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
De Chao Yu
CEO | Chief Executive Officer | 62 | 28/04/2011 |
Fei You
DFI | Director of Finance/CFO | 47 | 05/02/2024 |
Ghang Shou Gao
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
De Chao Yu
CHM | Chairman | 62 | 28/04/2011 |
Charles Cooney
BRD | Director/Board Member | 81 | 18/10/2015 |
Hao Xi Ede
BRD | Director/Board Member | 67 | 04/06/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.97% | +3.39% | +93.65% | +121.55% | 2.03TCr | |
| +0.61% | +0.23% | +33.28% | -7.11% | 7.7TCr | |
| +2.01% | -4.04% | +93.62% | +204.80% | 5.93TCr | |
| -0.93% | +60.10% | +60.10% | +60.10% | 5.07TCr | |
| -0.31% | -1.48% | -42.71% | -54.33% | 4.73TCr | |
| +0.76% | +2.53% | +49.52% | -39.64% | 2.6TCr | |
| -1.76% | +5.42% | +117.36% | -62.34% | 2.13TCr | |
| +2.62% | +1.82% | +68.05% | +32.55% | 1.95TCr | |
| +1.84% | +3.64% | +60.08% | +55.81% | 1.59TCr | |
| -0.98% | +2.90% | +126.60% | +406.60% | 1.49TCr | |
| Average | +0.29% | +1.10% | +65.95% | +71.80% | 3.52TCr | |
| Weighted average by Cap. | +0.38% | +0.32% | +53.94% | +56.09% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 1.33TCr 1.53TCr 195.67Cr 165.75Cr 152.51Cr 144.34Cr 267.5Cr 18TCr 272.2Cr 1.79TCr 700.37Cr 8.78TCr 733.99Cr 718.72Cr 31TCr | 1.8TCr 2.07TCr 264.76Cr 224.28Cr 206.36Cr 195.3Cr 361.96Cr 24TCr 368.31Cr 2.42TCr 947.66Cr 12TCr 993.15Cr 972.49Cr 42TCr |
| Net income | 164.14Cr 188.53Cr 24Cr 20Cr 19Cr 18Cr 33Cr 2.23TCr 33Cr 219.8Cr 86Cr 1.08TCr 90Cr 88Cr 3.81TCr | 264.23Cr 303.49Cr 39Cr 33Cr 30Cr 29Cr 53Cr 3.59TCr 54Cr 353.83Cr 138.74Cr 1.74TCr 145.4Cr 142.37Cr 6.13TCr |
| Net Debt | -1.07TCr -1.23TCr -156.67Cr -132.71Cr -122.11Cr -115.57Cr -214.18Cr -14TCr -217.94Cr -1.43TCr -560.76Cr -7.03TCr -587.67Cr -575.45Cr -25TCr | -1.54TCr -1.77TCr -226.03Cr -191.47Cr -176.18Cr -166.74Cr -309.01Cr -21TCr -314.44Cr -2.06TCr -809.05Cr -10TCr -847.89Cr -830.24Cr -36TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | 91.50 $ | -0.97% | 1,03,53,090 |
| 16/26/16 | 92.40 $ | +1.09% | 1,07,79,290 |
| 15/26/15 | 91.40 $ | +5.91% | 2,12,24,240 |
| 14/26/14 | 86.30 $ | -0.69% | 1,10,19,000 |
| 13/26/13 | 86.90 $ | -1.81% | 82,78,760 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 1801 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition